Partner Content Partner Content Why Does Quant-Led KOL Identification Fail In Growth Markets... When it comes to KOL identification mapping, there is no shortage of quant data around KOL and HCP activity out there.
Partner Content Partner Content Pathway To Effective Stakeholder Mapping Before developing any stakeholder engagement plan, it is crucial to have a clear understanding of all the relevant individuals and groups your product or device could directly impact or interest in
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.